RenovoRx, Inc.

Develops a device platform for delivering targeted therapies directly to solid tumors.

RNXT | NDAQ

Overview

Corporate Details

ISIN(s):: US75989R1077
LEI:
Country:: United States of America
Address:: 2570 W. EL CAMINO REAL, STE. 320,, 94040 MOUNTAIN VIEW
Website:: https://renovorx.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

RenovoRx, Inc. is a clinical-stage life sciences company developing targeted therapies for solid tumor cancers. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP™) platform utilizes its FDA-cleared RenovoCath® medical device to deliver therapeutic agents directly to the tumor site. This novel approach is designed to increase treatment efficacy and enhance patient safety by potentially minimizing the systemic toxicities associated with standard intravenous chemotherapy. RenovoRx's lead drug-device combination candidate is under evaluation in a pivotal Phase III clinical trial for locally advanced pancreatic cancer. Alongside its therapeutic development, the company is commercializing the RenovoCath device for targeted fluid delivery in the peripheral vascular system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all RenovoRx, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RenovoRx, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RenovoRx, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DENTIS CO.,LTD Develops dental implants, medical LED lighting, and CAD/CAM solutions for medical professionals.	South Korea	261200
DENTIUM Global manufacturer of premium dental implant systems and surgical tools for clinicians worldwide.	South Korea	145720
DENTSPLY SIRONA Inc. Global manufacturer of dental products, equipment, and digital solutions for professionals.	United States of America	XRAY
Deversify Health AB Developed mobile breathalyzers and apps for metabolic health for consumers, businesses & healthcare.	Sweden	DEV
Diagonal Bio AB Developing a platform for ultra-fast, PCR-accurate diagnostics of infectious diseases.	Sweden	DIABIO
Dignitana AB Develops a scalp cooling system for cancer patients to reduce hair loss during chemotherapy.	Sweden	DIGN
DIH HOLDING US, INC. Provides robotic and VR rehabilitation solutions for healthcare facilities worldwide.	United States of America	DHAI
DIO Corporation Global medical device company providing dental implants and innovative digital dentistry solutions.	South Korea	039840
DongBang Medical Co., Ltd. Manufactures devices for oriental medicine & aesthetics, including needles, threads, and fillers.	South Korea	240550
Draegerwerk AG & Co. KGaA Develops life-saving medical and safety technology for hospitals and industry.	Germany	DRW8